Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
- Written by PR Newswire
![]() |
SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, today announced a strategic partnership with CellCarta, a globally recognized provider of CRO laboratory services for pharmaceutical research and development. Under the...














